Antiepileptic Medication is the Subject of Recent Stevens Johnson Syndrome Lawsuit

Charleston, WVMylan Pharmaceuticals is facing a new lawsuit filed by a man who developed the potentially deadly skin disease Stevens Johnson Syndrome after using the generic form of one of the country's most prescribed antiepileptic drugs, Dilantin.

span itemprop="image" itemscope itemtype="https://schema.org/ImageObject" style="display:block">Juan Morales claims that he was prescribed the drug, also known as Phenytoin, to help treat his seizures in April 2008. In late May, Morales was hospitalized with a severe rash that covered most of his body. He was later diagnosed with Stevens Johnson Syndrome.

SJS is a violent and potentially fatal disease of the skin and subcutaneous tissues that has been connected to allergic reactions to antibiotics and other common medications. The disease causes lesions to form in the mucous membranes of an individual, effectively burning off a person's skin from the inside out.

Mylan manufactures a form of Phenytoin marketed as Phenytek, which the FDA labeled as an SJS risk in November 2008.

Morales is suing the company for failing to warn its customers of the potential risks involved in the use of Phenytek and for selling a defective product.